Document:

EX-4.1

 Exhibit 4.1 

EXECUTION VERSION 
 AMENDMENT
NO. 1 TO RIGHTS AGREEMENT 
 This Amendment No. 1 to Rights Agreement (the “Amendment”), dated as of July 26,
2016, to the Rights Agreement (as amended from time to time, the “Rights Agreement”), dated as of March 3, 2009, between Sequenom, Inc., a Delaware corporation (the “Company”), and American Stock
Transfer & Trust Company, LLC (the “Rights Agent”), is being executed at the direction of the Company. Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to such terms in the Rights
Agreement. 
 WHEREAS, the Company and the Rights Agent have executed and entered into the Rights
Agreement; 
 WHEREAS, pursuant to Section 27 of the Rights Agreement, prior to the Distribution
Date, the Company and the Rights Agent shall, if the Company so directs, supplement or amend any provision of the Rights Agreement without the approval of the holders of the Rights; 

WHEREAS, the Distribution Date has not occurred; 

WHEREAS, the Company, Laboratory Corporation of America Holdings, a Delaware corporation (“Parent”),
and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), propose to enter into an Agreement and Plan of Merger (as may be amended from time to time, the “Merger
Agreement”) pursuant to which, among other things, Purchaser will (a) commence a tender offer to acquire all of the outstanding shares of common stock of the Company, including any associated rights to purchase capital stock issued
pursuant to the Rights Agreement (such shares and associated rights, the “Shares” and such offer, the “Offer”), (b) subject to the terms and conditions set forth in the Merger Agreement, acquire Shares pursuant
to the Offer and (c) upon the completion of the Offer and subject to the other terms and conditions set forth in the Merger Agreement, merge with and into the Company (the “Merger”) with the Company surviving as a wholly owned
subsidiary of Parent, and each remaining Share will be converted into the right to receive cash consideration; 
 WHEREAS,
the Board of Directors of the Company has determined and resolved that it is in the best interest of the Company and its stockholders to modify the terms of the Rights Agreement to exempt the Merger Agreement and the transactions contemplated
thereby, including the Offer and the Merger, from the application of the Rights Agreement and has approved this Amendment and authorized its appropriate officers to execute and deliver the same to the Rights Agent; and 

WHEREAS, the Company desires to amend the Rights Agreement as set forth herein prior to entering into the Merger
Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and the agreements, provisions and
covenants herein contained, the parties agree as follows: 
 1. Amendment of Section 1.  

(a) Section 1 of the Rights Agreement is hereby amended and supplemented by adding the following new definitions thereto: 

  
 1 

 “Exempted Transactions” shall mean (i) the announcement,
approval, execution, delivery, performance and/or amendment of the Merger Agreement, or (ii) the announcement, approval, commencement, performance, consummation and/or amendment of the Offer, the Merger and/or any of the other transactions
contemplated by the Merger Agreement or any related agreements. 
 “Merger” shall have the meaning set forth
in the Merger Agreement. 
 “Merger Agreement” shall mean that certain Agreement and Plan of Merger to be
entered into on or about July 26, 2016, by and among the Company, Parent and Purchaser (as the same may be amended from time to time). 

“Offer” shall mean the tender offer to acquire all of the outstanding shares of the Company’s Common
Stock, including any associated rights to purchase capital stock issued pursuant to this Agreement, to be commenced by Purchaser pursuant to the Merger Agreement. 

“Parent” shall mean Laboratory Corporation of America Holdings, a Delaware corporation. 

“Purchaser” shall mean Savoy Acquisition Corp., a Delaware corporation. 

(b) The definition of “Acquiring Person” set forth in Section 1(a) of the Rights Agreement is hereby amended by adding
the following sentence to the end of such definition: 
 “Notwithstanding the foregoing or any provision to the
contrary in this Agreement, none of Purchaser, Parent, nor any of their respective stockholders, Affiliates or Associates are, nor shall any of them be deemed to be, an Acquiring Person by virtue of any of the Exempted Transactions.” 

(c) The definition of “Beneficial Owner,” “Beneficial Ownership” and “beneficially own” set forth in
Section 1(c) of the Rights Agreement is hereby amended by adding the following sentence to the end of such definition: 

“Notwithstanding anything in this definition to the contrary, none of Purchaser, Parent, nor any of their respective
stockholders, Affiliates or Associates shall be deemed to be the Beneficial Owner of, to have Beneficial Ownership of, nor to beneficially own, any Common Shares by virtue of any of the Exempted Transactions.” 

(d) The definition of “Distribution Date” set forth in Section 1(g) of the Rights Agreement is hereby amended by adding
the following proviso at the end of such definition: 
 “; provided, however, that a Distribution Date
shall not occur or be deemed to have occurred as a result of any of the Exempted Transactions.” 

  
 2 

 (e) The definition of “Interested Stockholder” set forth in Section 1(j) of
the Rights Agreement is hereby amended by adding the following sentence to the end of such definition: 

“Notwithstanding the foregoing or any provision to the contrary in this Agreement, none of Purchaser, Parent, nor any of
their respective stockholders, Affiliates or Associates are, nor shall any of them be deemed to be, an Interested Stockholder by virtue of any of the Exempted Transactions.” 

(f) The definition of “Shares Acquisition Date” set forth in Section 1(o) of the Rights Agreement is hereby amended by
adding the following sentence to the end of such definition: 
 “Notwithstanding anything else set forth in this
Agreement, a Shares Acquisition Date shall not be deemed to have occurred as a result of any of the Exempted Transactions.” 
 2.
Amendment of Section 3(a). Section 3(a) of the Rights Agreement shall be amended by adding the following sentence to the end thereof: 

“Notwithstanding anything else set forth in this Agreement, a Distribution Date shall not occur or be deemed to have
occurred as a result of any of the Exempted Transactions.” 
 3. Amendment of Section 7(a). Section 7(a) of the
Rights Agreement is hereby amended to delete the “or” immediately preceding clause (iii) and to add the following after clause (iii): 

“or (iv) immediately prior to the Offer Acceptance Time (as defined in the Merger Agreement).” 

4. Amendment of Section 11(a)(ii). Section 11(a)(ii) of the Rights Agreement is amended to add the following sentence
to the end thereof: 
 “Notwithstanding the foregoing, no provision for adjustment shall be made pursuant to this
Section 11(a)(ii) as a result of any of the Exempted Transactions.” 
 5. Amendment of Section 11(a)(iii).
Section 11(a)(iii) of the Rights Agreement is amended to add the following sentence to the end thereof: 

“Notwithstanding the foregoing, the Company shall not elect to take any of the actions contemplated by this
Section 11(a)(iii) as a result of any of the Exempted Transactions.” 
 6. Amendment of Section 13(a).
Section 13(a) of the Rights Agreement is amended to add the following sentence to the end thereof: 

  
 3 

 “Notwithstanding the foregoing, no provision contemplated by this
Section 13(a) shall be made pursuant to this Section 13(a) as a result of any of the Exempted Transactions and neither Parent, Purchaser nor any of their respective stockholders, Affiliates or Associates shall be deemed to be a Principal
Party as a result of any of the Exempted Transactions.” 
 7. Amendment of Section 15. Section 15 of the Rights
Agreement is amended to add the following sentence to the end thereof: 
 “Notwithstanding anything in this Agreement to
the contrary, nothing in this Agreement shall be construed to give any registered holder of the Rights Certificates (or, prior to the Distribution Date, the registered holders of the Common Shares) or any other Person any legal or equitable rights,
remedy or claim under this Agreement in connection with any of the Exempted Transactions.” 
 8. Addition of
Section 25(c). A new Section 25(c) is hereby added to the Rights Agreement, reading in its entirety as follows: 

“(c) Notwithstanding the foregoing or any provision to the contrary in this Agreement, the Company shall not be required
to give any notice contemplated by this Section 25 in connection with the Exempted Transactions, provided that the Company will endeavor to provide the Rights Agent with notice of the Offer Acceptance Time (as defined in the Merger
Agreement).” 
 9. Amendment of Section 30. Section 30 of the Rights Agreement is hereby amended to add the
following sentence at the end thereof: 
 “Nothing in this Agreement shall be construed to give any holder of Rights any
legal or equitable rights, remedies or claims under this Agreement by virtue of any of the Exempted Transactions.” 
 10.
Addition of Section 35. The following is hereby added as a new Section 35 of the Rights Agreement: 

“Section 35. Merger Agreement and Exempted Transactions; Termination. Notwithstanding anything in this
Agreement that might otherwise be deemed to the contrary, (i) none of Purchaser, Parent, nor any of their respective stockholders, Affiliates or Associates shall be deemed to be an Acquiring Person as a result of the Exempted Transactions,
(ii) a Shares Acquisition Date and a Distribution Date shall not be deemed to occur as a result of the Exempted Transactions, (iii) the rights hereunder will not separate from the Common Shares as a result of the Exempted Transactions, and
(iv) subject to the earlier termination of this Agreement, immediately prior to the Offer Acceptance Time (as defined in the Merger Agreement), this Agreement shall terminate and shall have no further force and effect and the Rights shall
expire and become null and void, without payment, liability or obligation on the part of the Company, the Rights Agent or the holders of any Rights.” 

  
 4 

 11. Effect of Amendment. This Amendment shall be and become effective immediately
prior to the execution and delivery of the Merger Agreement. If the Merger Agreement is terminated prior to the Offer Acceptance Time (as defined in the Merger Agreement), then this Amendment shall thereafter be null and void. Except as expressly
provided in this Amendment, the Rights Agreement is, and shall continue to be, in full force and effect in accordance with its terms, without amendment thereto, and is, in all respects, ratified and confirmed. 

12. Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all
purposes shall be governed by and construed in accordance with the laws of such State applicable to contracts to be made and performed entirely within such State. If any provision, covenant or restriction of this Amendment is held by a court of
competent jurisdiction or other authority to be invalid, illegal or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be effected, impaired
or invalidated. 
 13. Counterpart Signature Pages. This Amendment may be executed in one or more counterparts, all of which
shall be considered one and the same amendment and each of which shall be deemed an original. 
 [Signature Page Follows] 

  
 5 

 IN WITNESS WHEREOF, the
parties hereto have caused this Amendment to be duly executed and attested, all as of the day and year first above written. 
  

									
	SEQUENOM, INC.	 		 	 AMERICAN STOCK TRANSFER &

TRUST COMPANY, LLC, 
 As
Rights Agent

					
	By:	 	 /s/ Dirk van den Boom
	 		 	By:	 	 /s/ Paula Caroppoli

	Name: 	 	Dirk van den Boom, Ph.D.	 		 	Name: 	 	Paula Caroppoli
	Title:	 	President and CEO	 		 	Title:	 	Senior Vice President

  
 6Exhibit 4.1

 

FORM OF

 

RESTRICTED STOCK AWARD AGREEMENT

FOR
WELLESLEY BANCORP, INC.

2016
EQUITY INCENTIVE PLAN

 

This Award Agreement is provided to ___________________
(the “Participant”) by Wellesley Bancorp, Inc. (the “Company”) as of ______________________, 20___, (“Grant
Date”) the date the Compensation Committee of the Board of Directors of the Company (the “Committee”) awarded
the Participant a Restricted Stock Award pursuant to the Wellesley Bancorp, Inc. 2016 Equity Incentive Plan (the “2016
Plan”), subject to the terms and conditions of the 2016 Plan and this Award Agreement (referred to herein as the “Award”):

 

	 	1.	Number of Shares of Stock Subject 	 
	 	 	to Your Award:	_______ shares of Stock, subject to adjustment as may be necessary pursuant to Article 10 of the 2016 Plan.

 

	 	2. 	Grant Date:	_________________, 20___

  

Unless sooner vested in accordance with
Section 3 of the Terms and Conditions (attached hereto) or otherwise in the discretion of the Committee, the restrictions imposed
under Section 2 of the Terms and Conditions will expire as to the following percentages of the shares of Stock awarded hereunder,
on the dates noted below; provided that the Participant is still employed by or in service with the Company or any Affiliate:

 

	
        Percentage of

        Shares Vesting
	Number of Shares Vesting	
         

        Vesting Date

	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

IN WITNESS WHEREOF, Wellesley Bancorp, Inc.,
acting by and through the Compensation Committee of the Board of Directors, has caused this Award Agreement to be executed as of
the Grant Date set forth above.

 

		WELLESLEY BANCORP, INC.
	 	 	 
	 	 	 
	 	By:	 
	 	 	On behalf of the Compensation Committee

	Accepted by Participant:	 
	 	 
	 	 
	 	 
	 	 
	Date	 

 

 

     

     

    

 

TERMS AND CONDITIONS

 

		1.	Grant. The Grant Date and number of shares of Stock underlying your Award are stated on page 1 of this Award Agreement.
Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the 2016 Plan.

 

		2.	Restrictions. Your Award is subject to the following restrictions:

 

		(a)	Unvested Restricted Stock may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered.

 

		(b)	Upon your Termination of Service for any reason other than as set forth in paragraph (b) of Section 3 hereof, then you will
forfeit all of your rights, title and interest in this Award as of your termination date.

 

		(c)	Your Award is subject to the vesting schedule set forth on page 1 of this Award Agreement.

 

		3.	Expiration and Termination of Restrictions. The restrictions imposed under Section 2 will expire on the earliest to
occur of the following (the period prior to such expiration being referred to herein as the “Restricted Period”):

 

		(a)	As to the percentages of the Restricted Stock specified in the vesting schedule on page 1 of this Award Agreement, on the respective
dates specified in the vesting schedule on page 1; provided you have not experienced a Termination of Service; or

 

		(b)	Upon your Termination of Service by reason of death, Disability or within two years of a Change in Control (for reasons other
than Cause).

 

		5.	Delivery of Shares of Stock. Once the Restricted
Stock vests (see vesting schedule on page 1), the Stock will be distributed in accordance with your instructions.

  

		6.	Voting and Dividend Rights. As beneficial owner of the shares subject to the Restricted Stock Award, you have full voting
and dividend rights with respect to the Restricted Stock during and after the Restricted Period. You are also entitled to receive
a payment equal to any dividends, or other distributions declared and paid by the Company with respect to the Restricted Stock.
If you forfeit your rights under this Award Agreement in accordance with Section 2, you will no longer have any rights as a shareholder
with respect to the Restricted Stock and you will no longer be entitled to receive dividends on the shares of Restricted Stock.

 

		7.	Changes in Capital Structure. Upon the occurrence of a corporate event (including, without limitation, any stock dividend,
stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination
or exchange of shares of Stock), your Award will be adjusted as necessary to preserve the benefits or potential benefits of the
award. Without limiting the above, in the event of a subdivision of the outstanding Stock (stock-split), a declaration of a dividend
payable in Stock, or a combination or consolidation of the outstanding Stock into a lesser number of shares of Stock, the shares
of Stock subject to this Award Agreement will automatically be adjusted proportionately.

 

		8.	No Right of Continued Employment or Service. Nothing in this Award Agreement will interfere with or limit in any way
the right of the Company or any Affiliate to terminate your employment or service at any time, nor confer upon you any right to
continue in the employ or service of the Company or any Affiliate.

 

     

     

    

 

		9.	Payment of Taxes. You may make an election to be taxed upon your Award under Section 83(b) of the Code within 30 days
of the Grant Date. If you do not make an 83(b) Election, upon vesting of the Award the Committee is entitled to require
as a condition of delivery: (i) that you remit an amount sufficient to satisfy any and all federal, state and local (if any)
tax withholding requirements and employment taxes (i.e., FICA and FUTA), (ii) that the withholding of such sums come
from compensation otherwise due to you or from shares of Stock due to you under the 2016 Plan, or (iii) any combination of
the foregoing. Any withholding shall comply with Rule 16b-3 or any amendments or successive rules. Outside Directors are self-employed
and not subject to mandatory withholding.

 

		10.	Plan Controls. The terms contained in the 2016 Plan are incorporated into and made a part of this Award Agreement and
this Award Agreement shall be governed by and construed in accordance with the 2016 Plan. In the event of any actual or alleged
conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan will control.

 

		11.	Severability. If any one or more of the provisions contained in this Agreement is deemed to be invalid, illegal or unenforceable,
the other provisions of this Agreement will be construed and enforced as if the invalid, illegal or unenforceable provision had
never been included in this Agreement.

 

		12.	Notice. Notices and communications under this Agreement must be in writing and either personally delivered or sent by
registered or certified United States mail, return receipt requested, postage prepaid. Notices to the Company must be addressed
to:

 

[INSERT CONTACT]

 

or any other address designated by the Company in
a written notice to you. Notices to you will be directed to your address as then currently on file with the Company, or at any
other address that you provide in a written notice to the Company.

 

		13.	Successors. This Award Agreement shall be binding upon any successor of the Company, in accordance with the terms of
this Award Agreement and the 2016 Plan.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}]]